Ameritas Investment Partners, Inc. - ESPERION THERAPEUTICS INC NE ownership

ESPERION THERAPEUTICS INC NE's ticker is ESPR and the CUSIP is 29664W105. A total of 136 filers reported holding ESPERION THERAPEUTICS INC NE in Q2 2017. The put-call ratio across all filers is 3.87 and the average weighting 0.3%.

Quarter-by-quarter ownership
Ameritas Investment Partners, Inc. ownership history of ESPERION THERAPEUTICS INC NE
ValueSharesWeighting
Q1 2023$9,166
-76.2%
5,7650.0%0.00%
-100.0%
Q4 2022$38,568
+28.6%
5,765
+28.7%
0.00%
+100.0%
Q3 2022$30,000
+7.1%
4,4800.0%0.00%0.0%
Q2 2022$28,000
+33.3%
4,4800.0%0.00%0.0%
Q1 2022$21,000
+90.9%
4,480
+97.1%
0.00%
Q4 2021$11,000
-59.3%
2,2730.0%0.00%
-100.0%
Q3 2021$27,000
-43.8%
2,2730.0%0.00%
-50.0%
Q2 2021$48,000
-25.0%
2,2730.0%0.00%0.0%
Q1 2021$64,000
+8.5%
2,2730.0%0.00%
-33.3%
Q4 2020$59,000
-29.8%
2,2730.0%0.00%
-25.0%
Q3 2020$84,000
-28.2%
2,2730.0%0.00%
-33.3%
Q2 2020$117,000
+62.5%
2,2730.0%0.01%
+50.0%
Q1 2020$72,000
-44.2%
2,273
+4.9%
0.00%
-33.3%
Q4 2019$129,000
+76.7%
2,166
+8.7%
0.01%
+100.0%
Q3 2019$73,000
-21.5%
1,9930.0%0.00%
-25.0%
Q2 2019$93,000
+16.2%
1,9930.0%0.00%0.0%
Q1 2019$80,000
-13.0%
1,9930.0%0.00%
-20.0%
Q4 2018$92,000
+4.5%
1,9930.0%0.01%
+25.0%
Q3 2018$88,000
+12.8%
1,9930.0%0.00%0.0%
Q2 2018$78,000
-25.7%
1,993
+37.9%
0.00%
-20.0%
Q1 2018$105,000
+22.1%
1,445
+10.3%
0.01%
+25.0%
Q4 2017$86,000
+34.4%
1,3100.0%0.00%
+33.3%
Q3 2017$64,000
+4.9%
1,3100.0%0.00%0.0%
Q2 2017$61,000
+69.4%
1,310
+29.3%
0.00%
+50.0%
Q1 2017$36,0001,0130.00%
Other shareholders
ESPERION THERAPEUTICS INC NE shareholders Q2 2017
NameSharesValueWeighting ↓
Meditor Group Ltd 4,468,835$22,344,00010.09%
Altium Capital Management LP 2,515,785$12,579,0003.47%
Deep Track Capital, LP 5,641,668$28,208,0001.99%
Paradigm Biocapital Advisors LP 839,257$4,196,0001.20%
SABBY MANAGEMENT, LLC 940,400$4,702,0000.68%
Monaco Asset Management SAM 500,000$2,500,0000.62%
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) 5,000,000$25,000,0000.52%
CVI Holdings, LLC 1,460,595$7,303,0000.48%
PLATINUM INVESTMENT MANAGEMENT LTD 2,713,176$13,566,0000.38%
Rhenman & Partners Asset Management AB 1,000,000$4,960,0000.33%
View complete list of ESPERION THERAPEUTICS INC NE shareholders